🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Trastuzumab injection and Pertuzumab Injection and Docetaxel Injection and Carboplatin Injection

Found 16 matching trials

A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer

PHASE3

This is a Phase IIIb, multinational, multicenter, randomized, open-label st...

Status

Completed

Location

Centro de Investigaciones Médicas y Desarrollo LC S.R.L

Start Date

2022-07-05

Trial ID

NCT05415215

Treatments Being Tested

Fixed Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Use (PH FDC SC)Pertuzumab IV Trastuzumab IV Trastuzumab Emtansine Investigator's Choice of Chemotherapy Surgery Radiotherapy

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer

PHASE1

This is a study to compare the similarity in Pharmacokinetics (PK) profile ...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2026-07-03

Trial ID

NCT07601620

Treatments Being Tested

HLX319 EU-Phesgo®

A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer

PHASE3

This study is a multicenter, randomized, open-label, parallel Phase III cli...

Status

Active Not Recruiting

Location

Shengjing Hospital, China Medical University

Start Date

2025-10-23

Trial ID

NCT07196774

Treatments Being Tested

SHR-A1811 for Injection Docetaxel injection Trastuzumab Injection Carboplatin for Injection Pertuzumab Injection

Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

PHASE3

This randomized phase III trial studies docetaxel, carboplatin, trastuzumab...

Status

Completed

Location

Fairbanks Memorial Hospital

Start Date

2014-02-18

Trial ID

NCT02003209

Treatments Being Tested

Aromatase Inhibition Therapy Carboplatin Cytology Specimen Collection Procedure Docetaxel Goserelin Acetate Laboratory Biomarker Analysis Pertuzumab Quality-of-Life Assessment Therapeutic Conventional Surgery Trastuzumab Whole Breast Irradiation

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

PHASE2

This phase II trial studies the immunologic response and side effects of us...

Status

Recruiting

Location

Fred Hutch/University of Washington Cancer Consortium

Start Date

2022-04-20

Trial ID

NCT04329065

Treatments Being Tested

pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine Paclitaxel Trastuzumab Pertuzumab Docetaxel Carboplatin Ultrasound Imaging Biopsy Procedure Biospecimen Collection

Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

PHASE1

This phase Ib/II trial studies the side effects and best dose of ribociclib...

Status

Active Not Recruiting

Location

UCLA / Jonsson Comprehensive Cancer Center

Start Date

2022-04-07

Trial ID

NCT05319873

Treatments Being Tested

Carboplatin Docetaxel Fulvestrant Pertuzumab Quality-of-Life Assessment Ribociclib Trastuzumab Tucatinib

A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

PHASE3

This is a randomized, open, positive drug control, multi center phase III s...

Status

Recruiting

Location

The First Affiliated Hospital of Bengbu Medical University

Start Date

2025-09-15

Trial ID

NCT07043725

Treatments Being Tested

TQB2102 for injection Trastuzumab injection and Pertuzumab Injection and Docetaxel Injection and Carboplatin Injection

Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer

PHASE3

This is a multicenter, open label, non-inferiority, randomized controlled c...

Status

Recruiting

Location

Sunyat-sen Memorial Hospital

Start Date

2021-12-20

Trial ID

NCT05159193

Treatments Being Tested

pegylated liposomal doxorubicin (PLD)cyclophosphamide (C)trastuzumab (H)pertuzumab (P)docetaxel (T)docetaxel (T)carboplatin (Cb)trastuzumab (H)pertuzumab (P)

A Study for the Adjuvant Treatment of Breast Cancer

PHASE4

Studies on postoperative adjuvant albumin paclitaxel in domestic breast can...

Status

Recruiting

Location

2nd Affiliated Hospital, School of Medicine, Zhejiang University

Start Date

2022-07-10

Trial ID

NCT05420467

Treatments Being Tested

Docetaxel Carboplatin Trastuzumab Pertuzumab Nab paclitaxel Epirubicin Cyclophosphamide Docetaxel Epirubicin Cyclophosphamide Nab paclitaxel Cyclophosphamide

Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer

PHASE2

This study is a multicenter, prospective, randomized phase II trial designe...

Status

Not Yet Recruiting

Location

Guangdong Provincial People's Hospital

Start Date

2025-12-15

Trial ID

NCT07246317

Treatments Being Tested

QL1706 injection Trastuzumab (or biosimilar)Pertuzumab (or biosimilar)Docetaxel Carboplatin

Previous Next